NCT00616148View on ClinicalTrials.gov

Efficacy of YKP3089 in Patients With Photosensitive Epilepsy

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2010

Conditions
Epilepsy
Interventions
DRUG

YKP3089

Oral dosage form

DRUG

Placebo

Trial Locations (4)

10021

Cornell Medical Center, New York

10467

Montefiore Medical Center, The Bronx

19104

University of Pennsylvania Epilepsy Center, Philadelphia

21287

Johns Hopkins Medical Center, Baltimore

All Listed Sponsors
collaborator

The Epilepsy Study Consortium

OTHER

lead

SK Life Science, Inc.

INDUSTRY

NCT00616148 - Efficacy of YKP3089 in Patients With Photosensitive Epilepsy | Biotech Hunter | Biotech Hunter